Factors Affecting Completion of Adjuvant Chemotherapy in Early Stage Breast Cancer

被引：0
|
作者：
Reyes, S. A. [1 ]
Fei, K. [2 ]
Franco, R. [2 ]
King, T. A. [1 ]
Bickell, N. A. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mt Sinai Sch Med, New York, NY USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2015年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P52
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [21] Factors affecting the delivery of adjuvant/neoadjuvant chemotherapy in older women with breast cancer
    O'Connor, Tracey L.
    Edge, Stephen B.
    Kossoff, Ellen B.
    Groman, Adrienne
    Wilding, Gregory E.
    Ademuyiwa, Foluso O. .
    Levine, Ellis G.
    Watroba, Nancy
    Ngamphaiboon, Nuttapong
    JOURNAL OF GERIATRIC ONCOLOGY, 2012, 3 (04) : 320 - 328
  • [22] Adjuvant chemotherapy for early Breast Cancer
    Yuichi Takatsuka
    Takeshi Tominaga
    Breast Cancer, 2000, 7 (4) : 358 - 360
  • [23] Completion of adjuvant trastuzumab for older patients with early-stage breast cancer (BC).
    Freedman, Rachel A.
    Luis, Ines Maria Vaz Duarte
    Lin, Nancy
    Lii, Joyce
    Winer, Eric P.
    Keating, Nancy Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Early discontinuation of adjuvant chemotherapy in women with early stage breast cancer: The BQUAL study
    Neugut, Alfred I.
    Hillyer, Grace C.
    Kushi, Lawrence W.
    Lamerato, Lois
    Shim, Jinjoo
    Bovberg, Dana H.
    Nathanson, David
    Ambrisone, Christine B.
    Mandelblatt, Jeanne S.
    Magai, Carol
    Tsai, Wei Yann
    Jacobson, Judith S.
    Hershman, Dawn L.
    CANCER RESEARCH, 2015, 75
  • [25] Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer
    Duric, Vlatka M.
    Butow, Phyllis N.
    Sharpe, Louise
    Boyle, Frances
    Beith, Jane
    Wilcken, Nicholas R. C.
    Heritier, Stephane
    Coates, Alan S.
    Simes, R. John
    Stockler, Martin R.
    PSYCHO-ONCOLOGY, 2007, 16 (01) : 48 - 59
  • [26] Factors affecting time to adjuvant chemotherapy in stage III colon cancer patients.
    Holt, A.
    Nelson, R. A.
    Shibata, S.
    Lai, L. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer
    Maeda, Shingo
    Ouchi, Akira
    Komori, Koji
    Kinoshita, Takashi
    Sato, Yusuke
    Muro, Kei
    Taniguchi, Hiroya
    Masuishi, Toshiki
    Ito, Seiji
    Abe, Tetsuya
    Shimizu, Yasuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1081 - 1087
  • [28] The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study
    Stewart, Angela
    Collins, Barbara
    Mackenzie, Joyce
    Tomiak, Eva
    Verma, Shailendra
    Bielajew, Catherine
    PSYCHO-ONCOLOGY, 2008, 17 (02) : 122 - 130
  • [29] Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer
    Franceschini, D.
    De Rose, F.
    Iftode, C.
    D'Agostino, G. R.
    Navarria, P.
    Mancosu, P.
    Fogliata, A.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S700 - S700
  • [30] Adjuvant Chemotherapy in early stage Triple-Negative Breast Cancer Patients
    Pfeiler, G.
    Koenigsbergt, R.
    Natter, C.
    Jahn-Kuch, D.
    Hudec, M.
    Zeilinger, R.
    Dittrich, C.
    Singer, C.
    ONKOLOGIE, 2010, 33 : 26 - 26
12345